“…choice of therapy, treatment complications, evolution of functionality and quality of life, (overall) survival, etc.). [2][3][4][5][6] This can be related to important heterogeneity of the older population and lack of appropriate care standards caused by insufficient accrual of older persons in clinical trials. As a consequence, published data report on non-evidence based adjustments of treatment guidelines and increased likelihood of under-treatment with a possible negative effect on survival.…”